U.S. Contact Lenses Market Size and Share Analysis 2025-2033, Featuring Bausch & Lomb, Alcon, Carl Zeiss Meditec, The Cooper Companies, Hoya Corporation & More
RBC Capital Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $112.3
Alcon (ALC) Gets a Buy From RBC Capital
Deutsche Bank Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $103.26
Stocks That Could Be Safe From Tariffs Risk Compared to Their Industry Peers
UBS Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $111.63
Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Alcon (ALC) and Cooper Co (COO)
Alcon Stock Gains From Innovation Despite Macroeconomic Troubles
J.P. Morgan Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $105.88
Alcon's Earnings Call: Record Sales & Strategic Growth
Alcon Canada Strengthens Its Commitment to Astigmatic Patients With TOTAL30 for Astigmatism Expanded Parameters
Baird Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $108
Stifel Maintains Alcon(ALC.US) With Buy Rating, Maintains Target Price $100
A Quick Look at Today's Ratings for Alcon(ALC.US), With a Forecast Between $91.6 to $107
Baird Maintains Outperform on Alcon, Raises Price Target to $108
Analysts Conflicted on These Healthcare Names: Agilon Health (AGL), AN2 Therapeutics, Inc. (ANTX) and Alcon (ALC)
Alcon Full Year 2024 Earnings: EPS Beats Expectations
Express News | Alcon AG : Jefferies Raises Target Price to $110 From $100
Earnings Call Summary | Alcon(ALC.US) Q4 2024 Earnings Conference
Alcon Projects $10.2B-$10.4B Revenue in 2025 With Strong Product Launches